Global Diabetic Shoes Market, By Distribution Channel (Offline and Online), End- User (Women, Men, and Children), Patient Type (Inpatient and Outpatient) – Industry Trends and Forecast to 2031.
Diabetic Shoes Market Analysis and Size
Diabetic shoes play a crucial role in preventive foot care for diabetic patients. These shoes are designed to provide optimal support, cushioning, and fit, which helps minimize pressure points and reduces the risk of skin breakdown, blisters, and calluses. Ensuring an even distribution of weight and reducing friction, diabetic shoes help prevent the formation of foot ulcers, which are common and serious complications of diabetes. This preventive approach enhances the patient's quality of life and helps reduce healthcare costs associated with treating diabetic foot complications.
The global diabetic shoes market size was valued at USD 8.6 Billion in 2023 and is projected to reach USD 14.55 Billion by 2031, with a CAGR of 6.79% during the forecast period of 2024 to 2031. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, and consumer behaviour.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024-2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016 - 2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Distribution Channel (Offline and Online), End- User (Women, Men, and Children), Patient Type (Inpatient and Outpatient)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America
|
|
Market Players Covered
|
Healer Health, LLC (U.S.), OrthoFeet (U.S.), Pilgrim Shoes (U.S.), Podartis Srl (Italy), Propet Footwear (U.S.), Etonic (U.S.), Apexfoot (U.S.), Advanced Diabetic Solutions (U.S.), DARCO International (U.S.), THUASNE SA (France), SIGVARIS (Switzerland), Hanger Clinic (U.S.), Anodyne, LLC (U.S.), Pedors247 (U.S.), Apis Footwear Company (U.S.), The Foot Comfort Center (U.S.), Oasis Footwear, LLC. (U.S.), Reed Medical Ltd (U.K.), and PLS Pedorthic Lab Specialties, Inc (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Diabetic shoes are specially designed footwear that provides extra depth, cushioning, and support to reduce the risk of skin breakdown and foot complications in diabetic patients. They help prevent issues such as ulcers, infections, and amputations by offering enhanced protection and comfort.
Diabetic Shoes Market Dynamics
Drivers
- Increasing Awareness among Diabetic Patients
Educational campaigns by healthcare providers, government initiatives, and non-profit organizations are informing patients about the risks of diabetic foot complications and the benefits of using specialized footwear. This heightened awareness encourages more diabetic patients to adopt preventive measures, including wearing diabetic shoes, to avoid serious conditions such as ulcers and amputations. As a result, demand for these specialized shoes is rising, supporting market growth and expansion.
- Growing Aging Population
Aging population is more prone to developing diabetes, which leads to the high risk of foot complications such as neuropathy and poor circulation. This demographic group often requires specialized footwear to mitigate these risks and maintain mobility and independence. Consequently, the growing elderly population fuels demand for diabetic shoes as a crucial component of their diabetic management regimen, with a focus on finding the best diabetic shoes. Manufacturers and retailers are, therefore compelled to cater to this expanding market segment by offering a variety of diabetic shoe options tailored to the unique needs of older individuals.
Opportunities
- Growing Healthcare Initiatives
Healthcare organizations worldwide are spearheading initiatives to address the growing burden of diabetic foot complications. These initiatives include educational campaigns, subsidy programs, and partnerships with footwear manufacturers to promote the use of diabetic shoes. Emphasizing preventive care and early intervention, these efforts aim to reduce the incidence of foot ulcers, infections, and amputations among diabetic patients. Such initiatives raise awareness about the importance of foot health and drive demand for diabetic shoes, thereby fueling market growth. Healthcare policies that prioritize foot care and provide reimbursement for diabetic footwear further incentivize patients to invest in these specialized products, contributing to market expansion.
- Growing Advancements in Technology Enhances Diabetic Shoes Appeal
Technological advancements encompass various aspects, including materials, design, and manufacturing processes. For instance, the integration of 3D scanning technology allows for precise measurements and customization, ensuring a better fit and comfort for diabetic patients. Additionally, advancements in cushioning materials and orthotic inserts enhance support and alleviate pressure points, reducing the risk of foot complications. Such technological progress improves the efficacy and functionality of diabetic shoes and enhances their appeal and adoption among consumers, driving market expansion.
Restraints/Challenges
- High Significant Expense
Diabetic shoes often incorporate advanced materials, technologies, and customization processes to meet the unique needs of diabetic patients. As a result, production costs are higher, leading to elevated retail prices. This poses affordability challenges for many consumers, particularly those with limited financial resources or inadequate insurance coverage. The high cost may deter potential buyers from investing in diabetic shoes, thereby limiting market penetration and hindering access to essential foot care for diabetic individuals, ultimately impacting their overall health outcomes.
- Regulatory Challenges
Compliance with regulations such as quality standards, safety certifications, and labeling requirements adds complexity and costs to the manufacturing process. Moreover, navigating the regulatory landscape across different regions and countries poses logistical challenges for manufacturers, especially smaller companies with limited resources. Delays in obtaining regulatory approvals can hinder product launches and market entry, limiting the availability of diabetic footwear options for patients. These regulatory barriers create obstacles for market growth and innovation in the diabetic shoes industry.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In November 2023, Aetrex launched a new personalized footwear recommendation platform – FitStarter, developed with Heeluxe, to help retailers improve their shoe fitting service for shoppers, reduce returns, and increase customer satisfaction. This innovation is expected to enhance the global diabetic shoes market by offering better fit solutions, which is crucial for diabetic patients to prevent foot complications, thereby potentially reducing healthcare costs and boosting market growth
- In November 2023, Fyous, a custom-fit footwear brand, secured an Innovate U.K. match-funded grant of GBP 1.4 million to combat diabetic amputations. This funding will help expand their polymorphic molding technology combined with 3D scanning for custom-made footwear in healthcare. Such advancements are significant for the global diabetic shoes market as they address specific needs of diabetic patients, improve foot health, and reduce the risk of severe complications, driving demand for specialized footwear
- In February 2022, The American Diabetes Association collaborated with Dr. Comfort to take the next step in preventing and treating foot complications. This partnership highlights the importance of collaboration in the diabetic shoes market, promoting awareness and access to high-quality diabetic footwear. Such initiatives support the market by emphasizing preventive care, thereby increasing the adoption of diabetic shoes among patients to mitigate foot-related issues
Diabetic Shoes Market Scope
The market is segmented on distribution channel, end- user, and product type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Distribution Channel
- Offline
- Online
End- User
- Women
- Men
- Children
Patient Type
- Inpatient
- Outpatient
Diabetic Shoes Market Regional Analysis/Insights
The market is analysed and market size, volume information is provided by country, distribution channel, end-user, and patient type as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
Europe is expected to dominate the market due to a rise in obesity levels, which is closely linked to diabetes. In addition, there is an increasing number of women diagnosed with diabetes globally, contributing to higher demand for specialized footwear. The improvement in online retail penetration makes these products more accessible, and the rise in per capita income enables more consumers to afford such specialized health products. These elements collectively drive the market growth in Europe.
The country section of the market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Diabetic Shoes Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to the market.
Some of the major players operating in the market are:
- Healer Health, LLC (U.S.)
- OrthoFeet (U.S.)
- Pilgrim Shoes (U.S.)
- Podartis Srl (Italy)
- Propet Footwear (U.S.)
- Etonic (U.S.)
- Apexfoot (U.S.)
- Advanced Diabetic Solutions (U.S.)
- DARCO International (U.S.)
- THUASNE SA (France)
- SIGVARIS (Switzerland)
- Hanger Clinic (U.S.)
- Anodyne, LLC (U.S.)
- Pedors247 (U.S.)
- Apis Footwear Company (U.S.)
- The Foot Comfort Center (U.S.)
- Oasis Footwear, LLC. (U.S.)
- Reed Medical Ltd (U.K.)
- PLS Pedorthic Lab Specialties, Inc (U.S.)
SKU-